Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 43
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Am J Perinatol ; 40(15): 1644-1650, 2023 11.
Artículo en Inglés | MEDLINE | ID: mdl-34775581

RESUMEN

OBJECTIVE: This study aimed to compare the effectiveness of sustained uterine compression versus uterine massage in reducing blood loos after a vaginal delivery. STUDY DESIGN: This was a prospective randomized trial conducted at the American University of Beirut Medical Center (AUBMC) between October 2015 and October 2017. Inclusion criteria were women with a singleton pregnancy at ≥36 weeks of gestation, with less than three previous deliveries, who were candidates for vaginal delivery. Participants were randomized into two groups, a sustained uterine compression group (group 1) and a uterine massage group (group 2). Incidence of postpartum hemorrhage (blood loss of ≥500 mL) was the primary outcome. We assumed that the incidence of postpartum hemorrhage at our institution is similar to previously published studies. A total of 545 women were required in each arm to detect a reduction from 9.6 to 4.8% in the primary outcome (50% reduction) with a one-sided α of 0.05 and a power of 80%. Factoring in a 10% dropout rate. Secondary outcomes were admission to intensive care unit (ICU), postpartum complications, drop in hemoglobin, duration of hospital stay, maternal pain, use of uterotonics, or of surgical procedure for postpartum hemorrhage. RESULTS: A total of 550 pregnant women were recruited, 273 in group 1 and 277 in group 2. There was no statistically significant difference in baseline characteristics between the two groups. Type of anesthesia, rate of episiotomy, lacerations, and mean birth weight were also equal between the groups. Incidence of the primary outcome was not different between the two groups (group 1: 15.5%, group 2: 15.4%; p = 0.98). There was no statistically significant difference in any of the secondary outcomes between the two groups, including drop in hemoglobin (p = 0.79). CONCLUSION: There was no difference in blood loss between sustained uterine compression and uterine massage after vaginal delivery. KEY POINTS: · Transabdominal uterine compression and uterine massage are appropriate to prevent postpartum hemorrhage.. · No significant difference in blood loss or maternal discomfort observed between the two techniques.. · Both methods are equally effective and either one can be used based on provider preference..


Asunto(s)
Hemorragia Posparto , Femenino , Embarazo , Humanos , Masculino , Hemorragia Posparto/prevención & control , Estudios Prospectivos , Parto Obstétrico/efectos adversos , Masaje/métodos , Hemoglobinas
2.
J Obstet Gynaecol ; 41(7): 1010-1015, 2021 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-33432866

RESUMEN

Choosing the most suitable embryo remains challenging as the standard approach to select top-quality embryos for transfer rely on static morphological assessment. It is completed after fertilisation, on days 3 and 5 post oocyte retrieval and evaluates the size and number of blastomeres, presence of nucleation and percentage of fragmentation for cleavage stage embryos. Because of the limited number of observations during the morphological assessment, morphokinetic development of embryos has been implemented. It shows a broader image of embryo behaviour with precise evaluation of the timing of events. Yet, studies are inconsistent and debatable in predicting the parameters to identify chromosomal abnormalities. Pre-implantation genetic testing detects dysmorphic embryos and correlate their developmental potential to the assessed morphology. However, the clinical utility of PGT-aneuploidy remains controversial. The future relies on newly described scoring systems such as artificial intelligence and non-invasive PGT, yet their application and actual success rate still lacks supportive evidence.


Asunto(s)
Inteligencia Artificial , Embrión de Mamíferos/diagnóstico por imagen , Desarrollo Embrionario , Fertilización In Vitro/métodos , Pruebas Genéticas/métodos , Aneuploidia , Aberraciones Cromosómicas/embriología , Femenino , Humanos , Embarazo
4.
Am J Perinatol ; 34(4): 379-387, 2017 03.
Artículo en Inglés | MEDLINE | ID: mdl-27588932

RESUMEN

Objective The objective of this study was to determine the optimal dose of intravenous oxytocin administered during cesarean delivery (CD) to decrease the amount of blood loss. Methods Out of a total of 226 women presenting for CD, 189 patients were randomized into three groups by a computer-generated random number sequence table. Low-risk women with singleton term pregnancies undergoing scheduled CD were assigned to receive 20, 30, or 40 units (U) of oxytocin diluted in 500 mL of lactated Ringer solution intraoperatively. The primary outcome was the change in hemoglobin from pre-CD to post-CD. Results Overall, 63 women were assigned to each group. The primary outcome which was the drop in hemoglobin (1.4 ± 1.1 g/dL, 1.1 ± 0.8 g/dL, 1.0 ± 1.1 g/dL; p = 0.097) and the total calculated blood loss (798.6 ± 298.3 mL, 794.4 ± 313.5 mL, 820.2 ± 316.2 mL; p = 0.893) were not significantly different among the study groups. The incidence of intraoperative hypotension, postoperative systolic, and diastolic blood pressure changes was similar across the groups. Conclusion The amount of blood loss during CD was not significantly different among the three groups, thus the lowest dose of oxytocin infusion (20 U in 500 mL of lactated Ringer solution) seems to be an appropriate regimen.


Asunto(s)
Pérdida de Sangre Quirúrgica/prevención & control , Cesárea/efectos adversos , Complicaciones Intraoperatorias/prevención & control , Oxitócicos/administración & dosificación , Oxitocina/administración & dosificación , Administración Intravenosa , Adulto , Presión Sanguínea , Volumen Sanguíneo , Método Doble Ciego , Femenino , Hemoglobinas/metabolismo , Humanos , Hipotensión/etiología , Complicaciones Intraoperatorias/etiología , Periodo Posoperatorio , Embarazo
5.
BMC Pregnancy Childbirth ; 16: 98, 2016 May 04.
Artículo en Inglés | MEDLINE | ID: mdl-27146913

RESUMEN

BACKGROUND: The Middle East and North Africa region harbors significant proportions of stunting and wasting coupled with surging rates of non-communicable diseases (NCDs). Recent evidence identified nutrition during the first 1000 days of life as a common denominator not only for optimal growth but also for curbing the risk of NCDs later in life. The main objective of this manuscript is to describe the protocol of the first cohort in the region to investigate the association of nutrition imbalances early in life with birth outcomes, growth patterns, as well as early determinants of non-communicable diseases. More specifically the cohort aims to 1) examine the effects of maternal and early child nutrition and lifestyle characteristics on birth outcomes and growth patterns and 2) develop evidence-based nutrition and lifestyle guidelines for pregnant women and young children. METHODS/DESIGN: A multidisciplinary team of researchers was established from governmental and private academic and health sectors in Lebanon and Qatar to launch the Mother and Infant Nutritional Assessment 3-year cohort study. Pregnant women (n = 250 from Beirut, n = 250 from Doha) in their first trimester are recruited from healthcare centers in Beirut, Lebanon and Doha, Qatar. Participants are interviewed three times during pregnancy (once every trimester) and seven times at and after delivery (when the child is 4, 6, 9, 12, 18, and 24 months old). Delivery and birth data is obtained from hospital records. Data collection includes maternal socio-demographic and lifestyle characteristics, dietary intake, anthropometric measurements, and household food security data. For biochemical assessment of various indicators of nutritional status, a blood sample is obtained from women during their first trimester. Breastfeeding and complementary feeding practices, dietary intake, as well as anthropometric measurements of children are also examined. The Delphi technique will be used for the development of the nutrition and lifestyle guidelines. DISCUSSION: The Mother and Infant Nutritional Assessment study protocol provides a model for collaborations between countries of different socio-economic levels within the same region to improve research efficiency in the field of early nutrition thus potentially leading to healthier pregnancies, mothers, infants, and children.


Asunto(s)
Fenómenos Fisiológicos Nutricionales del Lactante , Fenómenos Fisiologicos Nutricionales Maternos , Evaluación Nutricional , Encuestas Nutricionales/métodos , Proyectos de Investigación , Adulto , Antropometría , Lactancia Materna , Desarrollo Infantil/fisiología , Estudios de Cohortes , Femenino , Humanos , Lactante , Líbano , Estilo de Vida , Madres , Embarazo , Resultado del Embarazo , Trimestres del Embarazo/sangre , Qatar
6.
Surg Technol Int ; 28: 192-5, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-27042794

RESUMEN

Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome is a congenital disorder characterized by uterine aplasia and aplasia of the upper part of the vagina. It presents with primary amenorrhea in a 46, XX individual. In this paper, we report the cases of two patients with MRKH syndrome treated with the laparoscopic modified Vecchietti technique using the optimized new instruments. A neovagina was successfully created in these two patients. This minimally invasive technique offers improvements in terms of operative time, complications, and functionality.


Asunto(s)
Trastornos del Desarrollo Sexual 46, XX/cirugía , Anomalías Congénitas/cirugía , Laparoscopía/instrumentación , Laparoscopía/métodos , Conductos Paramesonéfricos/anomalías , Estructuras Creadas Quirúrgicamente , Vagina/anomalías , Vagina/cirugía , Trastornos del Desarrollo Sexual 46, XX/diagnóstico por imagen , Adulto , Anomalías Congénitas/diagnóstico por imagen , Diseño de Equipo , Análisis de Falla de Equipo , Femenino , Humanos , Laparoscopios , Conductos Paramesonéfricos/diagnóstico por imagen , Conductos Paramesonéfricos/cirugía , Procedimientos de Cirugía Plástica/instrumentación , Procedimientos de Cirugía Plástica/métodos , Resultado del Tratamiento , Adulto Joven
7.
Reprod Biomed Online ; 26(1): 88-92, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23177418

RESUMEN

This prospective controlled nonrandomized pilot study was conducted to investigate whether split daily doses of recombinant human LH (rHLH) is more efficacious than the single daily dose in supporting follicular development and ovulation in primary hypogonadotrophic hypogonadism (HH). Twenty-seven women with HH received a 150 IU fixed daily subcutaneous dose of recombinant human FSH, supplemented by 75 IU daily dose of rHLH given either as a single dose (n=9; single-dose group) or four equally divided doses (n=18; split-dose group). Ovulation was defined by three efficacy end points: at least one follicle ⩾17mm in diameter, pre-ovulatory serum oestradiol ⩾400pmol/l and a midluteal progesterone ⩾25nmol/l. Although lacking statistical significance, the proportion of women in the rHLH split-dose group who fulfilled all three end points was higher than the single-dose group (72.2% versus 55.6%). Women in the split-dose group achieved higher serum oestradiol concentrations per follicle, endometrial thickness measurements and numbers of follicles than in the single-dose group (not statistically significant). The odds ratio for ovulation rate was 2.08 (not statistically significant). There were no serious untoward side effects. Administering rHLH in split daily doses could provide superior results compared with the traditional single daily dose. We conducted this clinical study to investigate whether a split daily dose protocol of recombinant human LH (rHLH) is more efficacious than the single daily dose in supporting follicular development and ovulation in primary hypogonadotrophic hypogonadism (HH). HH is an uncommon entity that can lead to very low or undetectable serum gonadotrophin concentrations. It manifests in anovulation, amenorrhoea and subsequent infertility. Twenty-seven women with HH received a 150 IU fixed daily subcutaneous dose of recombinant human FSH, supplemented by a 75 IU daily dose of rHLH given either as a single dose (n=9; single-dose group) or four equally divided doses (n=18; split-dose group). Ovulation was defined by these three efficacy end points: at least one follicle ⩾17mm in mean diameter, pre-ovulatory serum oestradiol concentration ⩾400pmol/l and a midluteal progesterone concentration ⩾25nmol/l. The proportion of women in the rHLH split-dose group who fulfilled all three end points was higher than the single-dose group (72.2% versus 55.6%). Women in the split-dose group achieved higher serum oestradiol concentrations per follicle, endometrial thickness measurements and numbers of follicles than in the single-dose group, without statistical significance. Women who received the split-dose regimen were more likely to have ovulation than the other group. We had no serious problematic side effects. Our results suggest that administering rHLH in split daily doses could provide superior results compared to the traditional single daily dose.


Asunto(s)
Hipogonadismo/tratamiento farmacológico , Hormona Luteinizante/administración & dosificación , Folículo Ovárico/efectos de los fármacos , Adolescente , Adulto , Endometrio/diagnóstico por imagen , Endometrio/efectos de los fármacos , Estradiol/sangre , Femenino , Humanos , Inyecciones Subcutáneas , Hormona Luteinizante/efectos adversos , Hormona Luteinizante/uso terapéutico , Oportunidad Relativa , Folículo Ovárico/crecimiento & desarrollo , Ovulación/efectos de los fármacos , Proyectos Piloto , Estudios Prospectivos , Proteínas Recombinantes/administración & dosificación , Proteínas Recombinantes/efectos adversos , Proteínas Recombinantes/uso terapéutico , Ultrasonografía
8.
Arch Sex Behav ; 42(8): 1627-35, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23979785

RESUMEN

Many cultural and religious beliefs place virginity at a high level of social significance, in that women who lose their virginity before marriage may face humiliation, ostracism, divorce, and extreme violence. This led to an increase in the demand for virginity restoration through surgical hymen reconstruction among these cultures. However, data regarding the acceptance of hymenoplasty in societies that consider sexuality a taboo are scarce. In this cross-sectional study, we investigated the effects of gender and religion on sexual attitudes towards hymenoplasty, premarital sex, and virginity in a sample of 600 Lebanese university students. Our findings showed that approval of hymenoplasty was low among participants regardless of gender (25.7 % men vs. 19.1 % women) and religious affiliations (22.5 % Muslims vs. 22.3 % Christians). Arguments for rejection were rooted in moral ethics and personal convictions: "form of deceiving and cheating" (80.7 %) and "betrayal of honesty in the relationship" (80.4 %). Reasons for acceptance included: personal belief in "women's rights, autonomy, and freedom" (72.2 %) and "physical harm and death" (63.5 %).Male participants were more likely to approve premarital coital sex than females (61.0 vs. 27.3 %). Muslims were also more likely to reject marrying a non-virgin than Christians (39.9 vs. 18.0 %). Female participants expressed more tolerance towards marrying a non-virgin male partner (78.3 vs. 57.3 %). Low acceptance of hymenoplasty among Lebanese university students was found to be related to moral ethics and personal convictions independently from gender and religious affiliation. Differences in sexual attitudes towards premarital coital sex and virginity, however, were more significantly influenced by culture and religion.


Asunto(s)
Actitud , Himen/cirugía , Matrimonio/etnología , Abstinencia Sexual/etnología , Conducta Sexual/etnología , Estudiantes/psicología , Adulto , Estudios Transversales , Cultura , Femenino , Identidad de Género , Procedimientos Quirúrgicos Ginecológicos/métodos , Humanos , Líbano , Modelos Logísticos , Masculino , Análisis Multivariante , Religión , Parejas Sexuales , Sexualidad , Encuestas y Cuestionarios , Universidades , Derechos de la Mujer
9.
Heliyon ; 9(4): e15515, 2023 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-37123967

RESUMEN

Objective: To report the case of a young woman with repeated conception failure, whose karyotype showed an unbalanced complex chromosomal rearrangement involving a large duplication harboring >115 genes and overlapping the 8p23.1 duplication syndrome region. The 8p23.1 duplication syndrome results from a tandem duplication on the short arm of chromosome 8 containing the 4 genes (GATA4, TNKS, SOX7, XKR6) responsible for the most common phenotypic features: developmental delay/learning disabilities, congenital heart disease and dysmorphism. Design: Case report and review of the literature. Setting: American University of Beirut Medical Center, department of Pathology and Laboratory medicine.Patient(s): Young woman referred to the genetic clinics for the workup of secondary idiopathic infertility with multiple unsuccessful inseminations and in vitro fertilizations. Interventions: Peripheral blood karyotype analysis from the patient and her parents. Elucidation of the CCR required whole chromosome painting Fluorescent in Situ Hybridization and Chromosomal Microarray. Main outcome measures: The few published reports on 8p23.1 duplication syndrome (<50 cases) describing carriers reveal a wide range of phenotypic consequences with heterogeneous severity. The main outcome is to further understand this syndrome. Results: Chromosomal microarray analysis detected a large (12Mb) pathogenic Copy Number Variant (CNV) at 8p23.3p23.1, overlapping the 8p23.1 duplication syndrome region. This CNV, classified as pathogenic, was shown to carry little significance in our patient. Conclusions: 8p23.1 duplication syndrome display a variable expressivity, ranging from overt syndromic features to minimal effect on the phenotype as shown in this case. Interpretation of prenatal detection of 8p23.1 duplication especially in preimplantation diagnosis is thus challenging. Nevertheless, this case emphasizes the importance of genetic testing in infertile patients displaying a normal phenotype.

10.
Diagnostics (Basel) ; 13(9)2023 Apr 26.
Artículo en Inglés | MEDLINE | ID: mdl-37174950

RESUMEN

Polycystic ovary syndrome (PCOS) is a complex and heterogeneous disorder that commonly affects women in the reproductive age group. The disorder has features that propose a blend of functional reproductive disorders, such as anovulation and hyperandrogenism, and metabolic disorders, such as hyperglycemia, hypertension, and obesity in women. Until today, the three implemented groups of criteria for the diagnosis of PCOS are from the National Institutes of Health (NIH) in the 1990s, Rotterdam 2003, and the Androgen Excess Polycystic Ovary Syndrome 2009 criteria. Currently, the most widely utilized criteria are the 2003 Rotterdam criteria, which validate the diagnosis of PCOS with the incidence of two out of the three criteria: hyperandrogenism (clinical and/or biochemical), irregular cycles, and polycystic ovary morphology. Currently, the anti-Müllerian hormone in serum is introduced as a substitute for the follicular count and is controversially emerging as an official polycystic ovarian morphology/PCOS marker. In adolescents, the two crucial factors for PCOS diagnosis are hyperandrogenism and irregular cycles. Recently, artificial intelligence, specifically machine learning, is being introduced as a promising diagnostic and predictive tool for PCOS with minimal to zero error that would help in clinical decisions regarding early management and treatment. Throughout this review, we focused on the pathophysiology, clinical features, and diagnostic challenges in females with PCOS.

11.
PLoS One ; 18(9): e0291249, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37683023

RESUMEN

Egg freezing is a relatively new and controversial procedure in the Arab region, challenging traditional perceptions of fertility and motherhood. This study aims to assess Lebanese women's awareness and acceptance of egg freezing and how these attitudes differ according to vary with age, socio-demographic characteristics, and educational level. We conducted a cross-sectional survey targeting Lebanese females aged between 18 and 39, involving 402 Lebanese women from six different institutions representing diverse cultural backgrounds. 65% of the respondents had heard of egg freezing. Younger women (18-30 years old) were 2.09 times more likely to consider egg freezing than those aged 31-39. Single women were 4.31 times more likely to consider egg freezing than women in relationships, while childless women were 5.00 times more likely compared to women who already had children. Overall, medical egg freezing was more widely accepted than social egg freezing. The most supported indication for social egg freezing was to enable women who struggled to find the right partner during their peak fertile years to have children in the future (41.5%). The most common concern that affected women's decision to undergo egg freezing was whether the procedure would be proven safe for their future children and whether it would affect their future fertility. Interestingly, in a relatively conservative country, concerns about hymenal disruption were the least prevalent, (19%). The most common concern by far was limited information on the procedure (62%). In conclusion, the study reveals that awareness and acceptance of social egg freezing among Lebanese women were higher than expected. Limited information on the procedure's details was the main impediment to higher acceptance rates, highlighting the importance of physicians and primary healthcare providers in providing reproductive-aged women with the necessary information to safeguard their reproductive potential.


Asunto(s)
Preservación de la Fertilidad , Mujeres , Humanos , Femenino , Adolescente , Adulto Joven , Adulto , Líbano , Mujeres/psicología , Preservación de la Fertilidad/psicología , Conocimiento , Actitud , Encuestas y Cuestionarios
12.
Int J Hyperthermia ; 28(8): 742-6, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23072616

RESUMEN

PURPOSE: This study aims to evaluate the effects of fever on follicular development in women undergoing controlled ovarian stimulation during in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI) cycles. MATERIALS AND METHODS: This was a retrospective observational self-controlled study at a tertiary-care fertility centre. Six gonadotropin stimulation cycles characterised by poor ovarian response in which women reported the occurrence of a febrile illness, were considered for evaluation. Fever-exposed cycles were compared to the next stimulation cycle in the same women. Primary outcome measures were final number of pre-ovulatory follicles (≥ 16 mm) and final peak serum estradiol levels (pg/mL). Other outcome measures were final number of medium-sized follicles (12-15 mm), final mean estradiol serum level per follicle ≥ 12 mm (pg/mL), total days of stimulation and total gonadotropin ampoules utilised. RESULTS: Fever-exposed cycles were associated with significantly lower number of pre-ovulatory follicles (0.7 ± 0.8), significantly higher number of medium-size follicles (21.0 ± 4.5), and significantly reduced serum estradiol per follicle ≥12 mm (50.7 ± 11.7 pg/mL). They also required a significantly longer duration of ovarian stimulation (15.7 ± 3.3 days) and a significantly increased number of gonadotropin ampoules (47.2 ± 10.9). Four women had polycystic ovary syndrome and one hypothalamic hypogonadism. CONCLUSION: This preliminary report suggests a possible negative effect of fever on follicular development and ovarian estradiol production in some women undergoing controlled ovarian stimulation.


Asunto(s)
Fiebre/fisiopatología , Folículo Ovárico/fisiopatología , Inducción de la Ovulación , Adulto , Estradiol/sangre , Femenino , Fertilización In Vitro , Humanos , Inyecciones de Esperma Intracitoplasmáticas
13.
Acta Obstet Gynecol Scand ; 91(6): 658-78, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22375613

RESUMEN

This article is a review of the literature assessing pregnancy outcomes and the effect of metformin treatment among women with polycystic ovary syndrome (PCOS). A review of research published in English was undertaken using PubMed and MEDLINE databases. The weight of the available evidence suggests that pregnant women with PCOS are at an increased risk of developing gestational diabetes, hypertensive disorders of pregnancy, preterm birth and early pregnancy loss. Obesity is a contributory factor for the increased risk of gestational diabetes in this group of women and is estimated to affect 5-40% of pregnant women with PCOS. The prevalence of other obstetric complications is estimated at 10-30% for gestational hypertension, 8-15% for pre-eclampsia and 6-15% for preterm birth. The association between PCOS and early pregnancy loss may not be direct, wherein the presence of PCOS-associated hyperinsulinemia, leading to hyperandrogenemia, has been implicated in the pathophysiology of early pregnancy loss. Apart from the role of metformin in improving the metabolic consequences accompanying PCOS, it has been shown to improve pregnancy rates in women with PCOS who are resistant to clomiphene citrate. In conclusion, pregnancy in women with PCOS is associated with adverse obstetric outcomes (multiple adverse obstetric risk). Whether metformin should be administered throughout pregnancy still remains controversial. Further prospective studies that foster a larger number of participants and adjust for all potentially confounding factors are needed.


Asunto(s)
Hipoglucemiantes/uso terapéutico , Metformina/uso terapéutico , Síndrome del Ovario Poliquístico/tratamiento farmacológico , Resultado del Embarazo , Aborto Espontáneo/etiología , Aborto Espontáneo/prevención & control , Diabetes Gestacional/etiología , Diabetes Gestacional/prevención & control , Femenino , Humanos , Hiperandrogenismo/tratamiento farmacológico , Hiperandrogenismo/etiología , Hiperinsulinismo/tratamiento farmacológico , Hiperinsulinismo/etiología , Hipertensión Inducida en el Embarazo/etiología , Hipertensión Inducida en el Embarazo/prevención & control , Infertilidad Femenina/etiología , Infertilidad Femenina/terapia , Obesidad/complicaciones , Obesidad/etiología , Síndrome del Ovario Poliquístico/complicaciones , Embarazo , Nacimiento Prematuro/etiología , Nacimiento Prematuro/prevención & control
14.
Acta Obstet Gynecol Scand ; 91(11): 1273-8, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22994379

RESUMEN

OBJECTIVE: To assess the psychological impact (Hospital Anxiety and Depression Scale) of an investigational ovarian stimulation protocol in women with premature ovarian failure (POF). DESIGN: Prospective longitudinal study. POPULATION: Ten women with POF. METHODS: Women with idiopathic POF were placed on three consecutive treatment cycles consisting of gonadotropin ovarian stimulation after estrogen priming, gonadotropin-releasing hormone agonist pituitary desensitization, and corticosteroid immune suppression. RESULTS: Median anxiety and depression scores increased significantly from baseline following three consecutive treatment cycles from 4.0 (range 2.0-8.0) to 11.0 (range 10.0-14.0) (p-value 0.041) and from 1.5 (range 0-6.0) to 9.0 (range 7.0-10.0) (p-value 0.039), respectively. There were nine "probable" anxiety (90%) and three "probable" depression (30%) cases on the final treatment cycle compared with none (0%) on baseline (p-value 0.004 and 0.250, respectively). CONCLUSIONS: The use of investigational ovarian stimulation protocols in women with idiopathic POF was associated with excessive psychological strain. Women with POF should be cautioned against the potentially harmful aspect of similar treatments of unproven benefit.


Asunto(s)
Infertilidad Femenina/terapia , Inducción de la Ovulación , Insuficiencia Ovárica Primaria/psicología , Adolescente , Adulto , Ansiedad/etiología , Buserelina/uso terapéutico , Gonadotropina Coriónica/uso terapéutico , Depresión/etiología , Estrógenos/uso terapéutico , Estrógenos Conjugados (USP)/uso terapéutico , Femenino , Glucocorticoides/uso terapéutico , Humanos , Infertilidad Femenina/etiología , Infertilidad Femenina/psicología , Inseminación Artificial , Estudios Longitudinales , Acetato de Medroxiprogesterona/uso terapéutico , Menotropinas/uso terapéutico , Ovario/diagnóstico por imagen , Prednisona/uso terapéutico , Insuficiencia Ovárica Primaria/complicaciones , Estudios Prospectivos , Escalas de Valoración Psiquiátrica , Sustancias para el Control de la Reproducción/uso terapéutico , Ultrasonografía , Adulto Joven
15.
Gynecol Endocrinol ; 28(4): 286-7, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22122545

RESUMEN

Chemotherapeutic agents administered for the treatment of malignancies can result in the incidence of premature ovarian failure (POF). Ovarian failure is reflected by elevated serum follicle-stimulating hormone (FSH) levels that may reach menopausal levels, at which the chances of a pregnancy are considered extremely rare. We report a case of a 26-year-old female who experienced two successful pregnancies, despite her diagnosis with chemotherapy-induced POF. This case suggests that patients who suffer from POF secondary to chemotherapy might still retain enough ovarian function with good quality oocytes that could support a healthy pregnancy.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Terapia de Reemplazo de Hormonas , Neoplasias Orbitales/tratamiento farmacológico , Insuficiencia Ovárica Primaria/tratamiento farmacológico , Rabdomiosarcoma/tratamiento farmacológico , Adulto , Femenino , Humanos , Neoplasias Orbitales/patología , Embarazo , Resultado del Embarazo , Insuficiencia Ovárica Primaria/inducido químicamente , Rabdomiosarcoma/patología
16.
BMC Complement Altern Med ; 12: 129, 2012 Aug 20.
Artículo en Inglés | MEDLINE | ID: mdl-22901284

RESUMEN

BACKGROUND: Complementary and alternative medicine (CAM) is widely used for the treatment of infertility. While the Middle East and North Africa region has been shown to house one of the fastest growing markets of CAM products in the world, research describing the use of CAM therapies among Middle-Eastern infertile patients is minimal. The aim of this study is to examine the prevalence, characteristics and determinants of CAM use among infertile patients in Lebanon. METHODS: A cross sectional survey design was used to carry out face-to-face interviews with 213 consecutive patients attending the Assisted Reproductive Unit at a major academic medical center in Beirut. The questionnaire comprised three sections: socio-demographic and lifestyle characteristics, infertility-related aspects and information on CAM use. The main outcome measure was the use of CAM modalities for infertility treatment. Determinants of CAM use were assessed through the logistic regression method. RESULTS: Overall, 41% of interviewed patients reported using a CAM modality at least once for their infertility. There was a differential by gender in the most commonly used CAM therapies; where males mostly used functional foods (e.g. honey & nuts) (82.9%) while females mostly relied on spiritual healing/prayer (56.5%). Factors associated with CAM use were higher household income (OR: 0.305, 95% CI: 0.132-0.703) and sex, with females using less CAM than males (OR: 0.12, 95% CI: 0.051-0.278). The older patients were diagnosed with infertility, the lower the odds of CAM use (p for trend <0.05). Almost half of the participants (48%) were advised on CAM use by their friends, and only 13% reported CAM use to their physician. CONCLUSIONS: The considerably high use of CAM modalities among Lebanese infertile patients, added to a poor CAM use disclosure to physicians, underscore the need to integrate CAM into the education and training of health professionals, as well as enhance infertile patients' awareness on safe use of CAM products.


Asunto(s)
Terapias Complementarias/estadística & datos numéricos , Infertilidad Femenina/terapia , Infertilidad Masculina/terapia , Adulto , Factores de Edad , Estudios Transversales , Curación por la Fe , Composición Familiar , Femenino , Amigos , Alimentos Funcionales , Humanos , Renta , Entrevistas como Asunto , Líbano , Masculino , Oportunidad Relativa , Relaciones Médico-Paciente , Prevalencia , Factores Sexuales , Espiritualidad
17.
BMJ Open ; 12(3): e057873, 2022 03 16.
Artículo en Inglés | MEDLINE | ID: mdl-35296487

RESUMEN

OBJECTIVES: COVID-19 has been recognised as a global health emergency necessitating collaborative efforts to halt further disease spread. The success of public health interventions and vaccination campaigns is contingent on the knowledge and awareness level of the public. We aim to assess COVID-19 knowledge and attitudes among Lebanese pregnant women and women seeking fertility treatment. DESIGN: Cross-sectional study using telehealth administered survey. SETTING: University-affiliated tertiary care centre. PARTICIPANTS: The data of 402-Lebanese women pregnant or seeking fertility treatment aged 20-45 years were analysed. OUTCOME MEASURES: Extent of COVID-19 general knowledge, pregnancy-specific knowledge and attitudes toward COVID-19 practices. RESULTS: All participants reported being knowledgeable about COVID-19, 70% of which rated their knowledge as 7 or more on a numerical scale of 0-10. The mean general COVID-19 knowledge was 22.15 (SD 2.44, range 14-27) indicating a high level of knowledge. The mean pregnancy-specific COVID-19 knowledge 6.84 (SD 2.061, range 0-10) indicated poorer pregnancy-specific knowledge compared with general COVID-19 knowledge. A trend towards higher knowledge was noted with higher income status. Reproductive age women with higher pregnancy-specific knowledge had more positive attitudes toward COVID-19 pregnancy practices. CONCLUSION: Our findings suggest a deficiency in pregnancy-specific COVID-19 knowledge stressing the necessity for targeted public health education interventions. It highlights the need for enhancing COVID-19 pregnancy-specific awareness which can serve as a stepping stone in the success of COVID-19 vaccination campaigns and in halting further disease spread.


Asunto(s)
COVID-19 , Mujeres Embarazadas , Adulto , COVID-19/epidemiología , COVID-19/prevención & control , Vacunas contra la COVID-19/uso terapéutico , Estudios Transversales , Brotes de Enfermedades , Femenino , Conocimientos, Actitudes y Práctica en Salud , Humanos , Persona de Mediana Edad , Embarazo , Adulto Joven
18.
PLoS One ; 17(6): e0269700, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35704645

RESUMEN

PURPOSE: Resilience is defined as the ability to face adversities with positive outcomes. Various scales have been utilized, including 25-item Connor-Davidson Resilience Scale (CD-RISC), to evaluate resilience among populations. Resilience research is scarce, particularly in Lebanon as no such scales have been validated. Thus, in the present work, we aimed to assess the psychometric properties of the Arabic version of CD-RISC. PATIENTS AND METHODS: The study was conducted at the Women's Health Center at the American University of Beirut Medical Center among Lebanese women presenting to the obstetrics and gynecology clinics. Internal validity of the Arabic CD-RISC was examined. Pearson's correlation coefficients between the scores of the Arabic version of CD-RISC and the other related constructs (Rosenberg Self-Esteem Scale, Dispositional Hope Scale, Life Orientation Test, and Positive and Negative Affect Schedule) were assessed to evaluate its divergent and convergent validity. We collected responses from a total of 63 Lebanese women. RESULTS: The studied scale displayed a high internal consistency. Adequate correlation coefficients were manifested by the significant positive moderate to strong and negative moderate correlations between the Arabic CD-RISC and the other related constructs. CONCLUSION: This is the first study to validate the Arabic version of the CD-RISC in a sample of Lebanese women. The findings of this study provide evidence that the Arabic version of CD-RISC is a reliable and valid tool for the evaluation of resilience among Lebanese women.


Asunto(s)
Resiliencia Psicológica , Análisis Factorial , Femenino , Humanos , Personalidad , Psicometría , Reproducibilidad de los Resultados , Encuestas y Cuestionarios
19.
PLoS One ; 17(4): e0266398, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35363827

RESUMEN

PURPOSE: To investigate the difference in character strengths (CSs) between patients with and without polycystic ovary syndrome (PCOS) and the association between biological (i.e., testosterone levels) and psychological factors (i.e., character strengths). PATIENTS AND METHODS: A total of 99 women divided into PCOS (49) and non-PCOS (50) groups who presented to the gynecological clinics at the women's center in the American University of Beirut Medical Center in 2017 were included. Women were assessed for testosterone bioavailable levels and completed a questionnaire that included Hospital Anxiety and Depression Scale and Values in Action Survey-72. Univariate and multivariable analyses were performed to examine the association of CSs between the two groups and its predictors. RESULTS: The scores of hope, judgement, perspective, and transcendence of the PCOS group were significantly higher in comparison with healthy participants. An increase in free androgen index was negatively correlated to the score of judgement only. CONCLUSION: Women with PCOS have their own profile of character strengths and virtues that constitute judgement, hope, perspective, and transcendence. This in turn can be utilized to reinforce those personality strengths and thus decrease the psychological distress and mood disorders accompanied with this disease.


Asunto(s)
Síndrome del Ovario Poliquístico , Distrés Psicológico , Femenino , Humanos , Síndrome del Ovario Poliquístico/complicaciones , Encuestas y Cuestionarios , Testosterona
20.
Ecancermedicalscience ; 14: 1033, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32419845

RESUMEN

Evidence suggests a likely negative impact of deleterious BRCA mutations on female fertility. Hence, different studies have aimed to address the reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients with a prime focus on their safety and efficacy. However, several uncertainties exist in many domains of this field. The aim of the current paper is to overview the reproductive potential and fertility preservation options in breast and ovarian cancer patients harbouring a BRCA mutation. We also discuss pre-implantation genetic testing in an attempt to help physicians during oncofertility counselling of these patients.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA